Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks

Symptoms of hereditary angioedema (HAE) attacks can recur soon after initial treatment; the durability of response for recombinant human C1 esterase inhibitor (rhC1INH) treatment is unknown.

http://ift.tt/2n87KRs